Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Return on Equity (2020 - 2022)

Historic Return on Equity for Ascendis Pharma A (ASND) over the last 3 years, with Q4 2022 value amounting to 1.65%.

  • Ascendis Pharma A's Return on Equity fell 12400.0% to 1.65% in Q4 2022 from the same period last year, while for Dec 2022 it was 1.65%, marking a year-over-year decrease of 12400.0%. This contributed to the annual value of 1.5% for FY2025, which is 14200.0% down from last year.
  • Per Ascendis Pharma A's latest filing, its Return on Equity stood at 1.65% for Q4 2022, which was down 12400.0% from 0.94% recorded in Q3 2022.
  • Ascendis Pharma A's Return on Equity's 5-year high stood at 0.42% during Q4 2021, with a 5-year trough of 1.65% in Q4 2022.
  • In the last 3 years, Ascendis Pharma A's Return on Equity had a median value of 0.54% in 2022 and averaged 0.68%.
  • Its Return on Equity has fluctuated over the past 5 years, first surged by 400bps in 2021, then tumbled by -12400bps in 2022.
  • Quarter analysis of 3 years shows Ascendis Pharma A's Return on Equity stood at 0.46% in 2020, then grew by 9bps to 0.42% in 2021, then plummeted by -298bps to 1.65% in 2022.
  • Its last three reported values are 1.65% in Q4 2022, 0.94% for Q3 2022, and 0.63% during Q2 2022.